Related Experiment Video

Updated: May 19, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

The pathogenesis of acute kidney impairment in patients with multiple myeloma

Vecihi Batuman1

  • 1Section of Nephrology and Hypertension, Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA. vbatuma@tulane.edu

Advances in Chronic Kidney Disease
|August 28, 2012
PubMed

Insights

Monoclonal free light chains (FLCs) cause acute kidney injury in myeloma by damaging kidney cells and forming casts. Reducing FLC levels is crucial for treating kidney problems in myeloma patients.

Area of Science:

  • Nephrology
  • Oncology
  • Immunology

Background:

  • Multiple myeloma can lead to acute kidney injury, a severe complication impacting patient prognosis.
  • Monoclonal free light chains (FLCs) are the primary mediators of kidney damage in myeloma.
  • FLC nephrotoxicity arises from direct cellular damage and intratubular cast formation.

Purpose of the Study:

  • To elucidate the mechanisms by which FLCs cause kidney injury in multiple myeloma.
  • To explain the link between FLCs, inflammation, and the development of chronic kidney disease in myeloma.
  • To identify therapeutic targets for mitigating FLC-induced renal damage.

Main Methods:

  • Review of existing literature on FLC nephrotoxicity and myeloma kidney disease.
  • Analysis of cellular and molecular pathways involved in FLC-mediated kidney damage.
  • Examination of inflammatory responses triggered by FLCs in proximal tubule cells.

Main Results:

  • FLCs exhibit variable toxicity, inhibiting tubular transport, causing Fanconi syndrome, oxidative stress, and cell death.
  • FLC endocytosis triggers inflammatory pathways via NF-κB and MAPK, leading to cytokine induction and epithelial-mesenchymal transition.
  • FLC burden correlates with kidney injury, but direct quantity-toxicity relationships vary among FLC species.

Conclusions:

  • Understanding FLC nephrotoxicity mechanisms provides a rationale for reducing FLC burden in myeloma patients with renal impairment.
  • Activated inflammatory pathways highlight opportunities for novel therapeutic interventions against myeloma kidney disease.
  • FLC toxicity explains acute kidney injury and chronic tubulointerstitial nephritis in multiple myeloma.

More Related Videos

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...